Kanso Diagnostics

Medical Devices & EquipmentSeedIsrael

Latest round

Seed

Last raised

Jun 2026

Total raised

$0.1M

Investors

5

About Kanso Diagnostics

Founded in 2021 and based in Israel, Kanso Diagnostics operates as a developer of a molecular diagnostics platform capable of at-home diagnostics with PCR and antigen tests. The company was co-founded by Omer Stoller (CEO) and Roy Rabinowitz. Kanso Diagnostics' product is its proprietary molecular diagnostics platform. This platform leverages CRISPR technology within a compact lab-on-a-chip device, enabling users to perform accurate bacterial and viral infection diagnostics conveniently at home. The system can be accessed by individuals without specialized medical training.

Who invested in Kanso Diagnostics

5 investors across 3 rounds

See all investors in Kanso Diagnostics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Jun 1, 2026

    Amount

    $0.1M

    Investors

    Locked

  2. Seed

    Jul 1, 2025

    Amount

    Undisclosed

    Investors

    Locked

  3. Seed

    Nov 1, 2023

    Amount

    Undisclosed

    Investors

    Locked

Questions about Kanso Diagnostics

Who invested in Kanso Diagnostics?

Kanso Diagnostics has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Kanso Diagnostics raised?

Kanso Diagnostics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Kanso Diagnostics last raise money?

Kanso Diagnostics's most recent round on record is a Seed, in Jun 2026.

What does Kanso Diagnostics do?

Founded in 2021 and based in Israel, Kanso Diagnostics operates as a developer of a molecular diagnostics platform capable of at-home diagnostics with PCR and antigen tests.

Where is Kanso Diagnostics headquartered?

Kanso Diagnostics is headquartered in Israel.

Which VCs invest in companies like Kanso Diagnostics?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back medical devices & equipment companies at Kanso Diagnostics's stage. Their profiles are linked below.

Raising like Kanso Diagnostics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.